Last edition
News about "Adar Poonawalla"
SII's HPV Vaccine Cervavac Receives WHO Prequalification
The Serum Institute of India’s Cervavac HPV vaccine has received WHO prequalification, supporting broader global prevention of HPV-associated diseases.
Adar Poonawalla | 06/10/2026 | By News Bureau
Vidal Health and SII Collaborate on HPV Vaccine Access
Vidal Health and Serum Institute of India (SII) have partnered to boost cervical cancer prevention, launching from 1 October 2025 a first-of-its-kind cashless platform for HPV vaccination—covering digital bookings, consent, and certification with zero paperwork.
Adar Poonawalla | 24/09/2025 | By Dineshwori | 229
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy